Friday, September 14, 2018 9:46:59 AM
Science is very much political! Groupthink is rampant. Going against the crowd takes courage and is often punished. Just look at the academic environment at universities. Come on, you think science is perfect discoverer of truth? Oh no, all human organizations are political. Eventually the truth wins out, like for Semelweis, in spite of all our biases, and sometimes after people like Semelweis were run out of town, ostracized and died alone - since nobody has the courage to look at the arguments of the "crazy" person suggesting radical new ideas with an open mind. It just "costs" too much to go out on a limb and accept radical new ideas.
Looking forward to this great advancement. It is real, and not fraud or showmanship. Your cell phone will still work.
Lots of people resist new technology and theories as impossible until there is sufficient proof. For BLP, it will be the Suncell producing huge power with no or little input. For NNVC, I suppose it will be a fairly large clinical trial showing good safety and reductions in viral disease. It's interesting that NNVC technology is presented as a "fairy tale," "pixie dust," and/or "flying carpet," similar to how Mills' work is criticized (e.g. "impossible against all the laws of physics" or "impossible or my cell phone wouldn't work," etc...).
I see that many other research groups have validated the whole viricide concept by creating other similar miniature virus killing machines. Hopefully one or more of them succeed, especially NNVC, despite the less than savory Diwan at the helm running the business. Would rather he stick to the science of producing the drugs for us. So far he has failed to provide NNVC with a drug they can take into clinic, and has run this company mostly for the benefit of himself by all appearances. For investors' sake and for the potential benefit to humanity, I really hope Diwan and Mills succeed soon.
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM